Introduced during the SCOPE Summit, PhaseV has presented a virtual solution that utilizes genuine EHR data to assess patient-level competition and eligibility prior to protocol lock. The announcement was made in Boston on February 2, 2026. This innovative tool aims to enhance clinical development by leveraging AI/ML technology.